Prostaglandin E 2 (PGE 2 ), originally discovered as a pro-inflammatory mediator, also inhibits several chemoattractant-elicited neutrophil functions, including adhesion, secretion of cytotoxic enzymes, production of superoxide anions, and chemotaxis. In this study, we have examined the effects of PGE 2 and prostaglandin E (EP) receptor-selective agonists/antagonists on several steps of the formyl-methionyl-leucyl-phenylalanine (fMLP)-induced phospholipase D (PLD) activation pathway in human neutrophils to elucidate the PGE 2 inhibitory mechanism. PGE 2 and EP 2 receptor agonists inhibited the stimulation of the activity of PLD induced by fMLP in a concentration-dependent manner. The fMLP-stimulated translocation to membranes of protein kinase C ␣, Rho, and Arf GTPases was diminished in the presence of PGE 2 or EP 2 agonists. Moreover, PGE 2 and EP 2 agonists decreased the activation of phosphatidylinositol 3-kinase ␥ (PI3K␥) and Tec kinases as well as the tyrosine phosphorylation of proteins stimulated by fMLP. These data provide strong evidence that 1) the inhibitory effects of PGE 2 on the fMLP-induced PLD activation pathway were mediated via EP 2 receptors and that 2) the suppression of PI3K␥ activity was the crucial step in the EP 2 -mediated inhibition of the fMLP-induced signaling cascade.
PGE(2) and other cAMP-elevating agents are known to down-regulate most functions stimulated by fMLP in human polymorphonuclear neutrophils. We reported previously that the inhibitory potential of PGE(2) resides in its capacity to suppress fMLP-stimulated PI-3Kgamma activation via the PGE(2) receptor EP(2) and hence, to decrease phosphatidylinositol 3,4,5-triphosphate [PI(3,4,5)P(3)] formation. Akt activity is stimulated by fMLP through phosphorylation on threonine 308 (Thr308) and serine 473 (Ser473) by 3-phosphoinositide-dependent kinase 1 (PDK1) and MAPK-AP kinase (APK)-APK-2 (MAPKAPK-2), respectively, in a PI-3K-dependent manner. Despite the suppression of fMLP-induced PI-3Kgamma activation observed in the presence of PGE(2), we show that Akt is fully phosphorylated on Thr308 and Ser473. However, fMLP-induced Akt translocation is decreased markedly in this context. PGE(2) does not affect the phosphorylation of MAPKAPK-2 but decreases the translocation of PDK1 induced by fMLP. Other cAMP-elevating agents such as adenosine (Ado) similarly block the fMLP-induced PI-3Kgamma activation process but do not inhibit Akt phosphorylation. However, Akt activity stimulated by fMLP is down-regulated slightly by agonists that elevate cAMP levels. Whereas protein kinase A is not involved in the maintenance of Akt phosphorylation, it is required for the inhibition of Akt translocation by PGE(2). Moreover, inhibition of fMLP-stimulated PI-3Kdelta activity by the selective inhibitor IC87114 only partially affects the late phase of Akt phosphorylation in the presence of PGE(2). Taken together, these results suggest that cAMP-elevating agents, such as PGE(2) or Ado, are able to induce an alternative mechanism of Akt activation by fMLP in which the translocation of Akt to PI(3,4,5)P(3)-enriched membranes is not required prior to its phosphorylation.
The aim of this study was to assess in human neutrophils theimplication of an adenosine 3′,5′-cyclic monophosphate (cAMP)-dependentpathway in the inhibitory effects of A2a receptor engagement. We foundthat Ro20-1724, a cAMP phosphodiesterase inhibitor, in the presence ofadenosine deaminase (ADA) or A2a receptor antagonists renderedtransient the fMLP-induced sustained increases in cAMP levels. The roleof A2a receptor stimulation was demonstrated by the ability of the A2areceptor agonist, CGS21680, to prevent ADA-mediated reduction of thepersistent cAMP elevation induced by fMLP. Persistent cAMP elevationcorrelated with inhibition of fMLP-induced PLD activation andrecruitment of Arf, RhoA, and PKC to membranes. The suppressive effectof CGS21680 or isoproterenol, a β-adrenergic receptor agonist, wasincreased by Ro20-1724 or by the adenylyl cyclase activator, forskolin, and reversed, at least in part, by the inhibitor of adenylyl cyclase,2′,5′-dideoxyadenosine. The activator of protein kinase A (PKA),Sp-cAMP inhibited fMLP-induced PLD activation and translocation of Arfand RhoA to membranes. In contrast, the suppression by A2a receptorstimulation of fMLP-induced PLD activation and cofactor recruitment wasantagonized by PKA inhibitors, Rp-cAMP and H89. In conclusion, A2areceptor occupancy by extracellular adenosine inhibits fMLP-inducedneutrophil activation via cAMP and PKA-regulated events.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.